POTLATCHDELTIC CORP (PCH)

US7376301039 - REIT

39.54  -0.04 (-0.1%)

After market: 39.54 0 (0%)

Fundamental Rating

3

Taking everything into account, PCH scores 3 out of 10 in our fundamental rating. PCH was compared to 28 industry peers in the Specialized REITs industry. PCH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PCH is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year PCH was profitable.
In the past year PCH had a positive cash flow from operations.
Each year in the past 5 years PCH has been profitable.
In the past 5 years PCH always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.50%, PCH is doing worse than 78.57% of the companies in the same industry.
PCH has a worse Return On Equity (0.81%) than 67.86% of its industry peers.
PCH has a Return On Invested Capital of 0.55%. This is amonst the worse of the industry: PCH underperforms 92.86% of its industry peers.
PCH had an Average Return On Invested Capital over the past 3 years of 10.43%. This is significantly above the industry average of 5.21%.
The last Return On Invested Capital (0.55%) for PCH is well below the 3 year average (10.43%), which needs to be investigated, but indicates that PCH had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.5%
ROE 0.81%
ROIC 0.55%
ROA(3y)9.31%
ROA(5y)7.49%
ROE(3y)15.13%
ROE(5y)12.54%
ROIC(3y)10.43%
ROIC(5y)9.04%

1.3 Margins

PCH has a worse Profit Margin (1.56%) than 78.57% of its industry peers.
In the last couple of years the Profit Margin of PCH has declined.
The Operating Margin of PCH (1.88%) is worse than 92.86% of its industry peers.
PCH's Operating Margin has declined in the last couple of years.
PCH has a Gross Margin of 9.67%. This is amonst the worse of the industry: PCH underperforms 85.71% of its industry peers.
PCH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.88%
PM (TTM) 1.56%
GM 9.67%
OM growth 3Y-43.89%
OM growth 5Y-25.85%
PM growth 3Y-27.67%
PM growth 5Y-13.62%
GM growth 3Y-28.97%
GM growth 5Y-14.99%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PCH is creating some value.
The number of shares outstanding for PCH has been reduced compared to 1 year ago.
Compared to 5 years ago, PCH has more shares outstanding
PCH has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.67, we must say that PCH is in the distress zone and has some risk of bankruptcy.
PCH has a Altman-Z score of 1.67. This is in the better half of the industry: PCH outperforms 75.00% of its industry peers.
The Debt to FCF ratio of PCH is 27.05, which is on the high side as it means it would take PCH, 27.05 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 27.05, PCH is doing worse than 67.86% of the companies in the same industry.
PCH has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PCH (0.43) is better than 96.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 27.05
Altman-Z 1.67
ROIC/WACC0.08
WACC7.11%

2.3 Liquidity

PCH has a Current Ratio of 1.24. This is a normal value and indicates that PCH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PCH (1.24) is better than 78.57% of its industry peers.
PCH has a Quick Ratio of 1.24. This is a bad value and indicates that PCH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.93, PCH is doing good in the industry, outperforming 67.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.93

4

3. Growth

3.1 Past

The earnings per share for PCH have decreased strongly by -66.98% in the last year.
The earnings per share for PCH have been decreasing by -24.46% on average. This is quite bad
The Revenue has been growing slightly by 3.49% in the past year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)-66.98%
EPS 3Y-41.85%
EPS 5Y-24.46%
EPS Q2Q%-86.21%
Revenue 1Y (TTM)3.49%
Revenue growth 3Y-0.54%
Revenue growth 5Y1%
Sales Q2Q%-3.91%

3.2 Future

Based on estimates for the next years, PCH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.41% on average per year.
PCH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.76% yearly.
EPS Next Y-68.9%
EPS Next 2Y17.79%
EPS Next 3Y18.41%
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y2.08%
Revenue Next 3Y2.76%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 188.29, the valuation of PCH can be described as expensive.
78.57% of the companies in the same industry are cheaper than PCH, based on the Price/Earnings ratio.
PCH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
The Price/Forward Earnings ratio is 49.31, which means the current valuation is very expensive for PCH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PCH indicates a slightly more expensive valuation: PCH is more expensive than 60.71% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.99, PCH is valued quite expensively.
Industry RankSector Rank
PE 188.29
Fwd PE 49.31

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PCH is valued expensively inside the industry as 82.14% of the companies are valued cheaper.
Based on the Price/Free Cash Flow ratio, PCH is valued a bit more expensive than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 80.47
EV/EBITDA 29.18

4.3 Compensation for Growth

PCH's earnings are expected to grow with 18.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.79%
EPS Next 3Y18.41%

4

5. Dividend

5.1 Amount

PCH has a Yearly Dividend Yield of 4.69%, which is a nice return.
Compared to an average industry Dividend Yield of 4.90, PCH has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, PCH pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.69%

5.2 History

The dividend of PCH decreases each year by -7.82%.
PCH has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-7.82%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

862.39% of the earnings are spent on dividend by PCH. This is not a sustainable payout ratio.
DP862.39%
EPS Next 2Y17.79%
EPS Next 3Y18.41%

POTLATCHDELTIC CORP

NASDAQ:PCH (12/24/2024, 7:30:46 PM)

After market: 39.54 0 (0%)

39.54

-0.04 (-0.1%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustrySpecialized REITs
Earnings (Last)10-28 2024-10-28/amc
Earnings (Next)01-27 2025-01-27/amc
Inst Owners89.06%
Inst Owner Change2.98%
Ins Owners2.43%
Ins Owner Change-0.49%
Market Cap3.11B
Analysts78.33
Price Target52.17 (31.94%)
Short Float %1.82%
Short Ratio3.63
Dividend
Industry RankSector Rank
Dividend Yield 4.69%
Dividend Growth(5Y)-7.82%
DP862.39%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-16 2024-12-16 (0.45)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.86%
Min EPS beat(2)8.47%
Max EPS beat(2)161.24%
EPS beat(4)2
Avg EPS beat(4)-9.14%
Min EPS beat(4)-106.29%
Max EPS beat(4)161.24%
EPS beat(8)4
Avg EPS beat(8)-4.7%
EPS beat(12)6
Avg EPS beat(12)-2.24%
EPS beat(16)9
Avg EPS beat(16)-0.52%
Revenue beat(2)2
Avg Revenue beat(2)4.48%
Min Revenue beat(2)4.18%
Max Revenue beat(2)4.79%
Revenue beat(4)3
Avg Revenue beat(4)2.97%
Min Revenue beat(4)-1.6%
Max Revenue beat(4)4.79%
Revenue beat(8)5
Avg Revenue beat(8)2.11%
Revenue beat(12)8
Avg Revenue beat(12)2.41%
Revenue beat(16)11
Avg Revenue beat(16)2.25%
PT rev (1m)0.56%
PT rev (3m)2.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-126.21%
EPS NY rev (1m)0%
EPS NY rev (3m)504.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.65%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)2.22%
Valuation
Industry RankSector Rank
PE 188.29
Fwd PE 49.31
P/S 2.94
P/FCF 80.47
P/OCF 16.85
P/B 1.52
P/tB 1.53
EV/EBITDA 29.18
EPS(TTM)0.21
EY0.53%
EPS(NY)0.8
Fwd EY2.03%
FCF(TTM)0.49
FCFY1.24%
OCF(TTM)2.35
OCFY5.94%
SpS13.44
BVpS26.05
TBVpS25.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.5%
ROE 0.81%
ROCE 0.65%
ROIC 0.55%
ROICexc 0.58%
ROICexgc 0.58%
OM 1.88%
PM (TTM) 1.56%
GM 9.67%
FCFM 3.66%
ROA(3y)9.31%
ROA(5y)7.49%
ROE(3y)15.13%
ROE(5y)12.54%
ROIC(3y)10.43%
ROIC(5y)9.04%
ROICexc(3y)11.76%
ROICexc(5y)10.13%
ROICexgc(3y)11.87%
ROICexgc(5y)10.23%
ROCE(3y)12.47%
ROCE(5y)10.81%
ROICexcg growth 3Y-51.06%
ROICexcg growth 5Y-29.96%
ROICexc growth 3Y-51%
ROICexc growth 5Y-29.9%
OM growth 3Y-43.89%
OM growth 5Y-25.85%
PM growth 3Y-27.67%
PM growth 5Y-13.62%
GM growth 3Y-28.97%
GM growth 5Y-14.99%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 27.05
Debt/EBITDA 6.39
Cap/Depr 124.72%
Cap/Sales 13.81%
Interest Coverage 250
Cash Conversion 134.86%
Profit Quality 233.94%
Current Ratio 1.24
Quick Ratio 0.93
Altman-Z 1.67
F-Score6
WACC7.11%
ROIC/WACC0.08
Cap/Depr(3y)82.13%
Cap/Depr(5y)75.02%
Cap/Sales(3y)7.15%
Cap/Sales(5y)6.41%
Profit Quality(3y)98.11%
Profit Quality(5y)123.96%
High Growth Momentum
Growth
EPS 1Y (TTM)-66.98%
EPS 3Y-41.85%
EPS 5Y-24.46%
EPS Q2Q%-86.21%
EPS Next Y-68.9%
EPS Next 2Y17.79%
EPS Next 3Y18.41%
EPS Next 5YN/A
Revenue 1Y (TTM)3.49%
Revenue growth 3Y-0.54%
Revenue growth 5Y1%
Sales Q2Q%-3.91%
Revenue Next Year3.32%
Revenue Next 2Y2.08%
Revenue Next 3Y2.76%
Revenue Next 5YN/A
EBIT growth 1Y-69.96%
EBIT growth 3Y-44.19%
EBIT growth 5Y-25.12%
EBIT Next Year149.28%
EBIT Next 3Y46.47%
EBIT Next 5YN/A
FCF growth 1Y-91.15%
FCF growth 3Y-48.99%
FCF growth 5Y-21.46%
OCF growth 1Y-63.76%
OCF growth 3Y-22%
OCF growth 5Y-2.32%